Market Cap 107.24M
Revenue (ttm) 2.27M
Net Income (ttm) -83.58M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -3,681.94%
Debt to Equity Ratio 0.00
Volume 1,263,700
Avg Vol 114,854
Day's Range N/A - N/A
Shares Out 9.39M
Stochastic %K 8%
Beta 2.66
Analysts Strong Sell
Price Target $115.40

Latest News on KRRO

Korro to Participate in Upcoming Investor Conferences

May 14, 2025, 4:05 PM EDT - 20 days ago

Korro to Participate in Upcoming Investor Conferences


Korro to Present at the Jefferies London Healthcare Conference

Nov 14, 2024, 8:00 AM EST - 7 months ago

Korro to Present at the Jefferies London Healthcare Conference


Korro Announces $70 Million Private Placement

Apr 18, 2024, 8:30 AM EDT - 1 year ago

Korro Announces $70 Million Private Placement


Korro Bio Appoints Dr. Rachel Meyers to Board of Directors

Nov 28, 2023, 8:00 AM EST - 1 year ago

Korro Bio Appoints Dr. Rachel Meyers to Board of Directors


Korro Bio and Frequency Therapeutics Announce Merger Agreement

Jul 14, 2023, 6:30 AM EDT - 2 years ago

Korro Bio and Frequency Therapeutics Announce Merger Agreement